Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
暂无分享,去创建一个
K. Rahbar | M. Morris | M. Desilvio | O. Sartor | R. Messmann | N. Vogelzang | V. Koshkin | S. Tagawa | K. Fizazi | K. Chi | J. D. de Bono | J. Calais | J. Nagarajah | J. Beauregard | A. Kendi | Xiao X. Wei | B. Chang | K. Herrmann | Bernd J. Krause | R. Ghouse